Thrombomodulin, an endothelium-bound protein that plays a role in the activated-protein C anticoagulant pathway and has been found to associate with endothelial dysfunction [44], has also been implicated as a potential biomarker in AAA, although conflicting data exists. This evidence concerns the gene THBD and triple-A syndrome.